Abacavir Sulfate

硫酸阿巴卡韦

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameAbacavir Sulfate
Drug Alias NameAbacavirum阿巴卡韦磺酸盐阿巴卡韦硫酸盐ZiagenZiagenavir +[9] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsAIDS Dementia ComplexHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaHIV Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1998/12/17
Country/TerritoryCanadaUnited StatesPuerto Rico +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesViiv Healthcare
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcViiv Healthcare BvGlaxo Operations Uk Ltd +[5] 
Inactive CompaniesBurroughs WellcomeGlaxo Wellcome IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsHIV Infections
Inactive IndicationsAIDS Dementia Complex

Other Information

ATC CodeJ05AF06
Related LinksWikipediaDrugBankKEGG